Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Calcutta HC sets aside...

    Calcutta HC sets aside Center's decision for strategic sale of Bengal Chemicals

    Written by Ruby Khatun Khatun Published On 2018-02-15T10:30:22+05:30  |  Updated On 15 Feb 2018 10:30 AM IST
    Calcutta HC sets aside Centers decision for strategic sale of Bengal Chemicals

    Kolkata: The Calcutta High Court has set aside the Centres decision to go for strategic sale of century-old Bengal Chemicals and Pharmaceuticals Ltd (BCPL), noting that a PSU is better equipped to provide affordable healthcare to people.



    The court, while passing the order, observed that BCPL's production is not limited to generic drugs as it manufactures snake anti-venom and cosmetics among other products.








    Quashing the Centre's decision on BCPL, Justice Debangshu Basak said that existence of a pharmaceutical company in the public sector will add to the availability of medicines at affordable rates to the citizens rather than subtract it.







    Noting that "availability of medicines at affordable rates is one of the pillars on which a robust healthcare facility is founded", the judge said, "The citizens must have access to affordable healthcare.


    "Affordable healthcare would necessarily bring within its wake availability of affordable medicines. A public sector undertaking manufacturing generic medicine would, therefore, be better placed and equipped to provide such a service," Justice Basak said in the order yesterday.


    The court said the decision of the central government, based on the recommendations of NITI Aayog to consider BCPL as falling under the non-priority sector, could not be sustained.


    The petitioner, Bengal Chemical Sramik Karmachari Union, had challenged the decision of strategic sale of BCPL taken by the Centre.


    The union's counsel Bikash Bhattacharya told the court that health being a priority sector, the central government was misplaced while treating the pharmaceutical industry as not a priority sector.


    He submitted that a parliamentary standing committee report of the current Lok Sabha had noted that the company had made stellar performance in the last few years and recommended that it be supported when it was on the path of regaining its past glory.


    Additional Solicitor General Kaushik Chanda submitted on behalf of the central government that it has taken a policy decision in not doing business in sectors which did not come within the priority sector.


    Manufacturing of pharmaceutical products did not come within the priority sector, Chanda stated in the court.


    He submitted that with regard to the revival of BCPL, the Union chemical and fertilizer ministry's pharmaceuticals department was of the view that although BCPL achieved net profit in the last few years, its net worth continued to remain negative.


    Therefore, the Cabinet had decided not to close down the company but put it up for strategic sale, he said.


    BCPL, the first chemical factory in the country, was founded by eminent scientist and entrepreneur Acharya Prafulla Chandra Roy in 1901 and at present has four factories in the country -- two in Kolkata and one each in Mumbai and Kanpur.


    After a sterling performance till the early 1950s, the company went downhill and started making losses from mid- 1950s.


    The company was taken over by the Government of India in 1977.


    Bengal Chemical doubled its sales turnover to Rs 88 crore in 2015-16, compared to Rs 45 crore in 2014-15, according to information made available by the company.

    BCPLBengal Chemical Sramik Karmachari UnionBengal Chemicals and Pharmaceuticals LtdBikash BhattacharyaCalcutta HCCalcutta High CourtHealthcareHigh CourtJustice Debangshu BasakNiti AayogPharmaceutical industrystrategic sale
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok